Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-07T19:20:56.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.5%
    Check dated 2025-04-30T13:57:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T08:38:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has removed extensive details about a clinical study involving nivolumab and ipilimumab for treating sarcoma and endometrial carcinoma, including study duration, patient criteria, and treatment protocols. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    52%
    Check dated 2025-04-16T02:04:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:13:23.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Ewing Sarcoma and has been revised to version 2.14.3, while references to Osteosarcoma and the previous version 2.14.2 have been removed.
    Difference
    0.3%
    Check dated 2025-04-01T18:51:40.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.